664-GENEVA: Modeling KRAS Inhibitor Responses

The paper introduces GENEVA, a scalable single-cell resolution platform designed to improve the accuracy of preclinical cancer drug testing. By creating mosaic tumor models that blend diverse patient-derived and cancer cell lines into single experiments, the platform captures how different genetic backgrounds respond to treatments simultaneously. Applying this technology to KRAS-G12C inhibitors, r...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动